MCAM and melanoma: These patients were examined for the presence of CTCs multiple times during the study, and a melanoma-specific commercially available ex vivo CellSearch system utilizing three markers (MelCAM, melanoma-associated chondroitin sulphate proteoglycan, and CD45) was used.